#AIEye #Podcast Episode 500 Special Edition: Interview with Veritone (NasdaqGS: $VERI) President Ryan Steelberg

#AIEye #Podcast Episode 500 Special Edition: Interview with Veritone (NasdaqGS: $VERI) President Ryan Steelberg

 

Point Roberts WA, Vancouver BC – December 23, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s special 500th edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/122320-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/12231Veritone-VERI.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence-e Episode 500: Veritone President Ryan Steelberg

 

Ryan Steelberg, President of Veritone, Inc. (NasdaqGS:VERI), returns to The AI Eye to discuss Veritone Automate Studio, the company’s “low-code, web-based workflow designer tightly integrated with aiWARE,” as described in the press release. This is the second appearance of Ryan Steelberg on the The AI Eye. He previously appeared on episode 377 to discuss the state of AI adoption in the TV industry.

 

About Veritone

Veritone (NASDAQ: VERI) is a leading provider of artificial intelligence (AI) technology and solutions. The company’s proprietary operating system, aiWARE™ powers a diverse set of AI applications and intelligent process automation solutions that are transforming both commercial and government organizations. aiWARE orchestrates an expanding ecosystem of machine learning models to transform audio, video, and other data sources into actionable intelligence. The company’s AI developer tools enable its customers and partners to easily develop and deploy custom applications that leverage the power of AI to dramatically improve operational efficiency and unlock untapped opportunities. Veritone is headquartered in Costa Mesa, California, and has offices in Denver, London, New York and San Diego. To learn more, visit veritone.com.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

#AI #Health Breaking News: GBT (OTCPINK: $GTCH) is Developing an AI Based Graphics Analytics System; #Artificialintelligence

#AI #Health Breaking News: GBT (OTCPINK: $GTCH) is Developing an AI Based Graphics Analytics System; #Artificialintelligence

 

SAN DIEGO - December 22, 2020 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company"), is developing an AI based graphic analytics system, targeted for medical imaging. As part of the company's plan to move forward towards the medical analytics field, we started research and development activities to seek and improve detection of diseases and symptoms using computer vision analysis.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2020/12221AI-Graphics-Analytics.asp

 

The efforts are invested into AI applications to detect and interpret medical images, like MRI, X-Ray, CT, PET and Ultrasound, with the goal of helping guiding physicians in capturing possible issues within scans of human organs. The project's internal name is "Imaging Predictive Analytics" (IPA) and it targets to analyze, alert and predict potential issues based on graphical data. We are focusing on getting the most value of our AI analytics power for images and scans of high resolution. The project is targeting the development of analysis technologies that can be used for biomedical purposes. For example, the aim of the IPA system is to be an added system to assist physicians with real time ultrasound scan to alert of potential suspicious findings that may be too small or unclear for the human eye. Another potential implementation would be to analyze MRI, CT and PET images to search and alert physicians for abnormalities. Medical images include high resolution data and the IPA system aims to automate the detection of abnormalities in commonly-ordered imaging in order to lead to quicker decision-making with the goal of reducing diagnostic errors in a wide variety of medical fields. One of these potential implementations is the cardiovascular field. Analyzing images to measure various structures of the heart can reveal risks for onset cardiovascular diseases or identify other abnormalities that may need to be addressed through surgery or medications. Another field is the respiratory area. This domain requires fast medical response in order to assist with respiratory therapy for patients with cardiopulmonary (heart/lung) illnesses and breathing difficulties, for example pneumonia and pneumothorax (Collapsed lung). It is our goal to use the IPA artificial intelligence based algorithms to provide for quick imaging analysis pointing physicians to provide the necessary treatment. The system is designed to incorporate deep learning methods and concepts that were initially developed within the company's Avant!-AI and Hipocrates system.

 

"According to our R&D plans 2021, we are moving forward to develop more advanced AI systems for the medical domain. Today's medical imaging consists of ultra high resolution scans that include numerous details. We started the development of our Imaging Predicting Analytics system, internal code name IPA, which we believe will be especially useful if fully developed when quick response is necessary. For example, in case of cardiovascular or respiratory conditions, a rapid imaging analytics may save lives by quickly finding anomalies that may be urgently addressed. The system is planned to have 2D and 3D simulation including rotations, cross sections and mapping. We already developed graphic analytics techniques within our Avant! AI system and now plan to further develop advanced deep learning imaging algorithms to analyze modern images of CT, MRI, X-RAY, PET and Ultrasound. We believe we will be able to target the system to assess images for evidence of abnormalities and alert providers to the potential diagnoses, with the goal of pointing subjects-of-interest to physicians, enabling faster treatment. The system is planned to use AI algorithms to learn the image parameters and train a neural network for pixels recognition and analytics. We intend for the the system to provide risk scores for areas of concern. We target to improve diagnostic's accuracy and potentially alert for risky factors, eliminating unnecessary tests and benign biopsies. We believe that medical imaging data is one of the richest sources of information, and one of the most complex ones. Artificial intelligence science has already proven to be an efficient assistant for radiologists and health professionals for the past decade, pursuing faster, more accurate, and comprehensive patient care. But our challenges are growing exponentially and so are our needs. 2D data is rapidly moving to 3D form, enabling better information representation in many medical fields. Today's imaging analytics complexity requires advanced computerized disciplines and a quantum leap approach in order to handle vast data, especially when real-time factor has become crucial. Our goal is to develop native graphic-rich disciplines to augment image analytics algorithms and flows, enabling better, and more accurate medicine and diagnostics."

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
GBT Technologies Inc.
Media: press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

 

 

 

 

#AIEye #Podcast #498: GBT (OTCPINK: $GTCH) Developing Expert System for qTerm Device, Predictiv AI (TSXV: $PAI.V) Donates ThermalPass Fever Detection System; #Artificialintelligence

#AIEye #Podcast #498: GBT (OTCPINK: $GTCH) Developing Expert System for qTerm Device, Predictiv AI (TSXV: $PAI.V) Donates ThermalPass Fever Detection System; #Artificialintelligence

 

Global #AI in Drug Development and Discovery to Reach $4.815 Billion by 2027

 

Point Roberts WA, Vancouver BC – December 17, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence  –  featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/121720-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/12171GBT-Predictiv.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (TSXV:PAI)

 

GBT Tokenize Corp., the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is developing an expert system – an artificial intelligence based computer program that solves problems that would usually require a human expert – based flow for its qTerm device mobile application. The aim of this, according to the press release, “will be to integrate machine learning functions to allow the expert system to acquire more and more knowledge from past experience and various external sources.” Danny Rittman, GBT's CTO, explained:

 

"We are preparing qTerm infrastructure for our qTerm vitals device and our goal is to develop an advanced flow for its mobile application. The mobile application flow is targeted to work with a backend server and together to run an expert system that will use a knowledge database and an inference engine. We believe that our qTerm device will become a health monitor device for users, enabling health-aware life. We believe this type of system can save lives for users with existing conditions.”

 

Predictiv AI Inc. (TSXV:PAI) has donated one of its ThermalPass fever detection systems to the Flemingdon Food Bank in Ontario, Canada, to “help keep patrons, staff, and volunteers, healthy and safe as demand for food banks continues to increase amid this busy and challenging holiday season.” Michael Lende, President and CEO of Predictiv AI, commented:

 

"ThermalPass can play an important role in the health and peace of mind of patrons, volunteers, and staff as it identifies individuals with an elevated temperature accurately and efficiently. Predictiv AI is proud to do our part in helping support the community during these difficult times."

 

Global AI in Drug Development and Discovery to Reach $4.815 Billion by 2027

 

A report published by Allied Market Research finds that the global AI in Drug Development and Discovery market will grow from $520 million in 2019 to $4.815 billion by 2027 with a compound annual growth rate (CAGR) of 31.6 percent in the forecast period 2020-2027. An excerpt from the report overview outlines the role of AI in the market:

 

Artificial intelligence has significant applications in the drug discovery field as it helps track diseases, create disease cures and predict which animal viruses appear to mutate. Artificial intelligence has been known to enhance R&D in drug discovery, which has helped researchers to discover chronic disease treatments. Drug discovery and development in the fields of medicine, pharmacology, and biotechnology are processes for the creation, design, and procurement of a drug through identifying a biological target, such as enzyme protein, gene, or receptor. Previously, the drugs were discovered by identifying the active ingredient conventional treatments. Thus, drug discovery is the first step in the process of identifying potential novel drugs and their medicinal purpose. New criteria for drugs are measured based on their bioavailability, efficacy, potency, and toxicity.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms.  GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software.  GBT’s system envisions the creation of a global mesh network.  The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com

Disclosure GTCH is a paid featured ai stock on investorideas

newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

#AI #Health #Stocks Breaking News: GBT Tokenize (OTCPINK: $GTCH) is Seeking to Develop an Expert System Based Flow qTerm Vitals' Device Mobile Application; #Artificialintelligence

#AI #Health #Stocks Breaking News: GBT Tokenize (OTCPINK: $GTCH) is Seeking to Develop an Expert System Based Flow qTerm Vitals' Device Mobile Application; #Artificialintelligence

 

SAN DIEGO - December 17, 2020 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company"), announced that its Joint Venture, GBT Tokenize Corp ("GBT/Tokenize"), is currently developing an expert system based flow for its qTerm device mobile application. An expert system is an artificial intelligence based computer program that solves problems that would usually require a human expert. An expert system typically relies on a knowledge base and fact analysis resources.

 

Read this news featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2020/12171qTerm-Mobile-Application.asp

 

The knowledge database is an organized collection of facts and rules about a topic. In qTerm, the database will be the user's vitals data and measurement that is taken over time. The facts analysis engine interprets and evaluates the knowledge base facts in order to provide the best answer for a query. Typical implementations of expert systems are data analysis, diagnostics, gaming, classifications or specific tasks. Upon a query the analysis engine fetches the relevant knowledge from the knowledge base, interprets it and to find a solution that is the most relevant to the problem. In an efficient expert system many facts are acquired and evaluated. The system provides the best answer to the query based on the provided knowledge.

 

GBT/Tokenize is developing a learning knowledge flow to be implemented within its qTerm mobile application. The goal of the flow will be to integrate machine learning functions to allow the expert system to acquire more and more knowledge from past experience and various external sources. The information will be categorized and classified for every user and stored in the user's private knowledge base. In this way each user will have personal own health history and private records. Furthermore, the new goal of the new flow will be to provide an explanation, statistics and alerts in case a potential health issue is predicted. For example, assuming the finalization of design and implementation, based on specific user measurements data, the expert system heuristic engine may reach a conclusion to recommend an immediate professional medical consultation which can be significant in early detection of diseases. It is the goal of the expert system to work as an integral part with a backend program, and will be constantly studying the user's health. The system will be self-learned just like a human being and improve from experience. The flow will provide feedback through the mobile application and a web application.

 

"We are preparing qTerm infrastructure for our qTerm vitals device and our goal is to develop an advanced flow for its mobile application. The mobile application flow is targeted to work with a backend server and together to run an expert system that will use a knowledge database and an inference engine. We believe that our qTerm device will become a health monitor device for users, enabling health-aware life. We believe this type of system can save lives for users with existing conditions," stated Danny Rittman, GBT's CTO

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
GBT Technologies Inc.
Media: press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories